Calibration of CTS5 in Women With Early Estrogen Receptor-Positive Breast Cancer Reply

被引：0
|
作者：
Noordhoek, Iris [1 ]
Putter, Hein [1 ]
Portielje, Johanneke E. A. [1 ]
Liefers, Gerrit-Jan [2 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 04期
关键词：
TAMOXIFEN;
D O I：
10.1200/JCO.20.03015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：339 / +
页数：3
相关论文
共 50 条
  • [1] Calibration of CTS5 in Women With Early Estrogen Receptor-Positive Breast Cancer
    Dowsett, Mitch
    Sestak, Ivana
    Cuzick, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (04) : 338 - +
  • [2] Usefulness of CTS5 for the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    Tajiri, Wakako
    Sugii, Azusa
    Ijichi, Hideki
    Ueo, Hiroki
    Koga, Chinami
    Nakamura, Yoshiaki
    Okamoto, Masahiro
    Taguchi, Kennichi
    Tokunaga, Eriko
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [3] Usefulness of CTS5 for the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    Tajiri, W.
    Masuda, T.
    Ijichi, H.
    Koga, C.
    Tanaka, J.
    Nakamura, Y.
    Okamoto, M.
    Tokunaga, E.
    [J]. BREAST, 2019, 44 : S18 - S18
  • [4] The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    Tajiri, Wakako
    Ijichi, Hideki
    Takizawa, Katsumi
    Koi, Yumiko
    Masuda, Takanobu
    Ueo, Hiroki
    Koga, Chinami
    Nakamura, Yoshiaki
    Taguchi, Kenichi
    Okamoto, Masahiro
    Tokunaga, Eriko
    [J]. BREAST CANCER, 2021, 28 (01) : 67 - 74
  • [5] The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    Wakako Tajiri
    Hideki Ijichi
    Katsumi Takizawa
    Yumiko Koi
    Takanobu Masuda
    Hiroki Ueo
    Chinami Koga
    Yoshiaki Nakamura
    Kenichi Taguchi
    Masahiro Okamoto
    Eriko Tokunaga
    [J]. Breast Cancer, 2021, 28 (1) : 67 - 74
  • [6] Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor-Positive Breast Cancer Treated With 5 Years of Endocrine Therapy: CTS5
    Dowsett, Mitch
    Sestak, Ivana
    Regan, Meredith M.
    Dodson, Andrew
    Viale, Giuseppe
    Thuelimann, Beat
    Colleoni, Marco
    Cuzick, Jack
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (19) : 1941 - +
  • [7] Benefit of paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer - Reply
    Henderson, IC
    Norton, L
    Berry, DA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) : 4465 - 4466
  • [8] Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    Mansell, James
    Monypenny, Ian J.
    Skene, Anthony I.
    Abram, Paul
    Carpenter, Robert
    Gattuso, Jennifer M.
    Wilson, Christopher R.
    Angerson, Wilson J.
    Doughty, Julie C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (01) : 91 - 98
  • [9] Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer
    James Mansell
    Ian J. Monypenny
    Anthony I. Skene
    Paul Abram
    Robert Carpenter
    Jennifer M. Gattuso
    Christopher R. Wilson
    Wilson J. Angerson
    Julie C. Doughty
    [J]. Breast Cancer Research and Treatment, 2009, 117 : 91 - 98
  • [10] Using the CTS5 Score to Predict Late Recurrence in Male and Female Estrogen Receptor-Positive Breast Cancer Patients: a SEER database analysis of 65,729 cases
    Wang, Fenhua
    Ren, Fang
    Qian, Jian
    Xu, Yunxia
    Wu, Jiayi
    Zong, Yu
    Gu, Xidong
    [J]. CANCER RESEARCH, 2024, 84 (09)
12345